CD8A and neoplasm: By specifically targeting antigen-presenting cells inside the tumor microenvironment, ExoSTING was able to boost immune activation by encouraging local Th1 responses, CD8+ T cell recruitment, and systemic anti-tumor immunity against the tumor.